Linkedin Facebook Twitter Youtube

20 Sep Mana.bio

Posted at 19:46h in by

Peter Nell, Ph.D., Advisory Board Member

Oct. 10 | 3:30pm | Rentschler ATMP Ballroom

Tel-Aviv, Israel

(Private)

Mana.bio leverages AI/ML to design novel non-viral ex-liver cell-specific RNA delivery solutions. Mana Bio is a seed-stage biotech company leveraging data, machine learning, and high throughput screening to design novel LNPs for extrahepatic delivery of nucleic acid therapeutics and vaccines. Mana was founded by a team of repeat entrepreneurs and highly regarded experts in the field of drug delivery, machine learning, and software development. Mana built predictive AI models and achieved novel IP-protected in vivo results, including lung-specific delivery of mRNA. The company is now open to leveraging this technology platform for collaborations with biotech and pharma companies to optimize formulations for cell-specific delivery of a wide range of payloads, such as mRNA, CRISPR gRNA, siRNA and more.

www.mana.bio



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 7-9, 2024
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions